Physician profile
Archana Jayakumar
NPI 1780145383
$1,942.81
in general payments reported to CMS, 2019-2025
20 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,160 · 2024: $327 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122 · Travel and Lodging: $802 · Consulting Fee: $18.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.74 |
| Travel and Lodging | $802.24 |
| Consulting Fee | $18.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,096.18 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $150.92 | 2024-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Avadel Cns Pharmaceuticals, LLC | $96.37 | 2024-2025 | Lumryz |
| Harmony Biosciences LLC | $92.47 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $81.17 | 2024-2025 | Airsupra, Fasenra |
| Jazz Pharmaceuticals INC. | $63.75 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.24 | 2025 | Cuvitru, Eohilia |
| Verona Pharma, INC. | $52.97 | 2025 | Ohtuvayre |
| Csl Behring | $45.80 | 2024-2025 | Hizentra |
| Axsome Therapeutics, INC. | $31.74 | 2025 | Sunosi |
| Aerin Medical INC. | $20.46 | 2025 | |
| Pharming Healthcare, INC. | $20.30 | 2025 | Ruconest |
| Adma Biomanufacturing LLC | $18.83 | 2025 | |
| Lilly USA, LLC | $18.36 | 2025 | Mounjaro, Zepbound |
| Blueprint Medicines Corporation | $16.79 | 2023 | Ayvakit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.65 | 2023 | Ofev |
| Merck Sharp & Dohme LLC | $16.45 | 2023 | |
| Kaleo, INC. | $16.16 | 2024 | Auvi-Q |
| Ars Pharmaceuticals Operations, INC. | $15.96 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $14.24 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archana Jayakumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.